Hostname: page-component-7c8c6479df-7qhmt Total loading time: 0 Render date: 2024-03-28T15:11:12.524Z Has data issue: false hasContentIssue false

Recurrent infective endocarditis in a patient after a second Melody valve placement

Published online by Cambridge University Press:  05 June 2020

Daiji Takajo*
Affiliation:
Department of Pediatrics, Children’s Hospital of Michigan, Detroit, MI, USA
Thomas J. Forbes
Affiliation:
Division of Pediatric Cardiology, Department of Pediatrics, Children’s Hospital of Michigan, Wayne State University, Detroit, MI, USA
Sanjeev Aggarwal
Affiliation:
Division of Pediatric Cardiology, Department of Pediatrics, Children’s Hospital of Michigan, Wayne State University, Detroit, MI, USA
*
Author for correspondence: Daiji Takajo, Children’s Hospital of Michigan, 3901 Beaubien Boulevard, Detroit, MI48201, USA. Tel: +1 313 745 1892; Fax: +1 313 993 7118. E-mail: dt1449@gmail.com

Abstract

A 16-year-old Caucasian male was diagnosed with recurrent infective endocarditis associated with his second Melody valve placed inside a previously treated infected Melody valve. The replacement of Melody valve after the first infective endocarditis episode might increase the risk of the second episode of infective endocarditis.

Type
Brief Report
Copyright
© The Author(s), 2020. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hascoet, S, Mauri, L, Claude, C, et al.Infective endocarditis risk after percutaneous pulmonary valve implantation with the Melody and sapien valves. JACC Cardiovasc Interv 2017; 10: 510517.10.1016/j.jcin.2016.12.012CrossRefGoogle ScholarPubMed
Abdelghani, M, Nassif, M, Blom, NA, et al.Infective endocarditis after melody valve implantation in the pulmonary position: a systematic review. J Am Heart Assoc 2018; 7: e008163.10.1161/JAHA.117.008163CrossRefGoogle ScholarPubMed
Haas, NA, Bach, S, Vcasna, R, et al.The risk of bacterial endocarditis after percutaneous and surgical biological pulmonary valve implantation. Int J Cardiol 2018; 268: 5560.10.1016/j.ijcard.2018.04.138CrossRefGoogle ScholarPubMed
Lehner, A, Haas, NA, Dietl, M, et al.The risk of infective endocarditis following interventional pulmonary valve implantation: a meta-analysis. J Cardiol 2019; 74: 197205.10.1016/j.jjcc.2019.04.007CrossRefGoogle ScholarPubMed
Patel, M, Malekzadeh-Milani, S, Ladouceur, M, et al.Percutaneous pulmonary valve endocarditis: incidence, prevention and management. Arch Cardiovasc Dis 2014; 107: 615624.10.1016/j.acvd.2014.07.052CrossRefGoogle ScholarPubMed
Van Dijck, I, Budts, W, Cools, B, et al.Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants. Heart 2015; 101: 788793.10.1136/heartjnl-2014-306761CrossRefGoogle ScholarPubMed
O’Donnell, C, Holloway, R, Tilton, E, et al.Infective endocarditis following Melody valve implantation: comparison with a surgical cohort. Cardiol Young 2017; 27: 294301.10.1017/S1047951116000494CrossRefGoogle ScholarPubMed
Malekzadeh-Milani, S, Houeijeh, A, Jalal, Z, et al.French national survey on infective endocarditis and the Melody valve in percutaneous pulmonary valve implantation. Arch Cardiovasc Dis 2018; 111: 497506.10.1016/j.acvd.2017.10.007CrossRefGoogle ScholarPubMed
McElhinney, DB, Sondergaard, L, Armstrong, AK, et al.Endocarditis after transcatheter pulmonary valve replacement. J Am Coll Cardiol 2018; 72: 27172728. doi: 10.1016/j.jacc.2018.09.039.CrossRefGoogle ScholarPubMed
Malekzadeh-Milani, S, Ladouceur, M, Patel, M, et al.Incidence and predictors of Melody® valve endocarditis: a prospective study. Arch Cardiovasc Dis 2015; 108: 97106.CrossRefGoogle ScholarPubMed
Cahill, TJ, Prendergast, BD.Infective endocarditis. Lancet 2016; 387: 882893.10.1016/S0140-6736(15)00067-7CrossRefGoogle ScholarPubMed